Reticulon 3-dependent ER-PM contact sites control EGFR nonclathrin endocytosis.

Fabrizio Bianchi, Sara Sigismund, Pier Paolo Di Fiore, Simona Polo, Carlo Tacchetti, Paolo Pinton, Davide Mazza, Emanuele Martini, Tiziana Bonaldi, Alessandro Cuomo, Giusi Caldieri, Maria Grazia Malabarba, Stefano Confalonieri, Lisette G G C Verhoef, Alexia Conte, Massimo Bonora, Andrea Raimondi, Gilda Nappo, Elisa Barbieri

Journal: Science (New York, N.Y.) 2018;356(6338):617-624

PMID: 28495747

Abstract

The integration of endocytic routes is critical to regulate receptor signaling. A nonclathrin endocytic (NCE) pathway of the epidermal growth factor receptor (EGFR) is activated at high ligand concentrations and targets receptors to degradation, attenuating signaling. Here we performed an unbiased molecular characterization of EGFR-NCE. We identified NCE-specific regulators, including the endoplasmic reticulum (ER)-resident protein reticulon 3 (RTN3) and a specific cargo, CD147. RTN3 was critical for EGFR/CD147-NCE, promoting the creation of plasma membrane (PM)-ER contact sites that were required for the formation and/or maturation of NCE invaginations. Ca release at these sites, triggered by inositol 1,4,5-trisphosphate (IP)-dependent activation of ER Ca channels, was needed for the completion of EGFR internalization. Thus, we identified a mechanism of EGFR endocytosis that relies on ER-PM contact sites and local Ca signaling.

Copyright © 2017, American Association for the Advancement of Science.

Address: Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), Via Adamello 16, 20139 Milan, Italy.; Centro Imaging Sperimentale, Istituto Scientifico San Raffaele, Via Olgettina 52, 20132 Milan, Italy.; Section of Pathology, Oncology and Experimental Biology and Laboratory for Technologies of Advanced Therapies Center, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy.; Dipartimento di Oncologia ed Emato-Oncologia (DiPO)-Università degli Studi di Milano, Via Festa del Perdono 7, 20122 Milan, Italy.; Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milan, Italy.; Dipartimento di Medicina Sperimentale, Università degli Studi di Genova, Genoa, Italy.; Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), Via Adamello 16, 20139 Milan, Italy. [email protected] [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.